Literature DB >> 35912858

Concerns about the inverse relationship between baseline HBV DNA and on-treatment hepatocellular carcinoma risk. Reply.

Won-Mook Choi, Young-Suk Lim.   

Abstract

Entities:  

Keywords:  Hepatitis; Hepatology

Mesh：

Substances：

Year:  2022        PMID： 35912858      PMCID： PMC9337818          DOI： 10.1172/JCI161425

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   19.456


× No keyword cloud information.
  7 in total

1.  Confounding: what it is and how to deal with it.

Authors:  K J Jager; C Zoccali; A Macleod; F W Dekker
Journal:  Kidney Int       Date:  2007-10-31       Impact factor: 10.612

2.  Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score.

Authors:  Hwai-I Yang; Man-Fung Yuen; Henry Lik-Yuen Chan; Kwang-Hyub Han; Pei-Jer Chen; Do-Young Kim; Sang-Hoon Ahn; Chien-Jen Chen; Vincent Wai-Sun Wong; Wai-Kay Seto
Journal:  Lancet Oncol       Date:  2011-04-14       Impact factor: 41.316

3.  Changes in serum levels of HBV DNA and alanine aminotransferase determine risk for hepatocellular carcinoma.

Authors:  Chuen-Fei Chen; Wen-Chung Lee; Hwai-I Yang; Hung-Chuen Chang; Chin-Lan Jen; Uchenna H Iloeje; Jun Su; Chuhsing K Hsiao; Li-Yu Wang; San-Lin You; Sheng-Nan Lu; Chien-Jen Chen
Journal:  Gastroenterology       Date:  2011-06-22       Impact factor: 22.682

4.  Cost-effectiveness of antiviral treatment in adult patients with immune-tolerant phase chronic hepatitis B.

Authors:  Hye-Lin Kim; Gi-Ae Kim; Jae-A Park; Hye-Rim Kang; Eui-Kyung Lee; Young-Suk Lim
Journal:  Gut       Date:  2020-11-25       Impact factor: 23.059

5.  Moderate levels of serum hepatitis B virus DNA are associated with the highest risk of hepatocellular carcinoma in chronic hepatitis B patients.

Authors:  Gi-Ae Kim; Seungbong Han; Gwang Hyeon Choi; Jonggi Choi; Young-Suk Lim
Journal:  Aliment Pharmacol Ther       Date:  2020-04-14       Impact factor: 8.171

6.  Increasing on-treatment hepatocellular carcinoma risk with decreasing baseline viral load in HBeAg-positive chronic hepatitis B.

Authors:  Won-Mook Choi; Gi-Ae Kim; Jonggi Choi; Seungbong Han; Young-Suk Lim
Journal:  J Clin Invest       Date:  2022-05-16       Impact factor: 19.456

7.  Presence of Liver Inflammation in Asian Patients With Chronic Hepatitis B With Normal ALT and Detectable HBV DNA in Absence of Liver Fibrosis.

Authors:  Jiacheng Liu; Jian Wang; Xiaomin Yan; Ruifei Xue; Jie Zhan; Suling Jiang; Yu Geng; Yilin Liu; Minxin Mao; Juan Xia; Shengxia Yin; Xin Tong; Yuxin Chen; Weimao Ding; Rui Huang; Chao Wu
Journal:  Hepatol Commun       Date:  2021-11-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.